JPH0134038B2 - - Google Patents
Info
- Publication number
- JPH0134038B2 JPH0134038B2 JP11155385A JP11155385A JPH0134038B2 JP H0134038 B2 JPH0134038 B2 JP H0134038B2 JP 11155385 A JP11155385 A JP 11155385A JP 11155385 A JP11155385 A JP 11155385A JP H0134038 B2 JPH0134038 B2 JP H0134038B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- ursocholic
- culture
- deoxycholic
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BHQCQFFYRZLCQQ-UTLSPDKDSA-N ursocholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-UTLSPDKDSA-N 0.000 claims description 51
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims description 38
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims description 31
- 229960003964 deoxycholic acid Drugs 0.000 claims description 31
- 244000005700 microbiome Species 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000222356 Coriolus Species 0.000 claims description 4
- 241000123294 Daedaleopsis Species 0.000 claims description 4
- 241000222350 Pleurotus Species 0.000 claims description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 3
- 241000223218 Fusarium Species 0.000 claims description 3
- 241001480581 Marasmius Species 0.000 claims description 3
- 241001236144 Panaeolus Species 0.000 claims description 3
- 241001480579 Crinipellis Species 0.000 claims description 2
- 241000722337 Pholiota Species 0.000 claims description 2
- 238000000034 method Methods 0.000 description 31
- 239000002609 medium Substances 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 9
- 229960001661 ursodiol Drugs 0.000 description 9
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 7
- 239000004380 Cholic acid Substances 0.000 description 7
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 7
- 235000019416 cholic acid Nutrition 0.000 description 7
- 229960002471 cholic acid Drugs 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000879295 Fusarium equiseti Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 102100039358 3-hydroxyacyl-CoA dehydrogenase type-2 Human genes 0.000 description 2
- 108010032887 7 beta-hydroxysteroid dehydrogenase Proteins 0.000 description 2
- 108010014831 7-alpha-hydroxysteroid dehydrogenase Proteins 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000221198 Basidiomycota Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 2
- 240000001462 Pleurotus ostreatus Species 0.000 description 2
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 2
- 241001138370 Pleurotus pulmonarius Species 0.000 description 2
- 244000158441 Pleurotus sajor caju Species 0.000 description 2
- 235000004116 Pleurotus sajor caju Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000583946 Crinipellis scabella Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000654305 Daedaleopsis styracina Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000123326 Fomes Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000258931 Marasmius siccus Species 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001156632 Panaeolus sphinctrinus Species 0.000 description 1
- 244000168667 Pholiota nameko Species 0.000 description 1
- 235000014528 Pholiota nameko Nutrition 0.000 description 1
- 241000908220 Pleurotus salmoneostramineus Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- -1 octene Chemical compound 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
[産業上の利用分野]
本発明は、ウルソデオキシコール酸製造の中間
原料としてのウルソコール酸を製造する方法に関
するものである。
[従来の技術]
3α、7β、12α−トリヒドロキシ−5β−コラン−
24−酸(3α、7β、12α−trihydroxy−5β−
cholanic acid)は、第4図の[]の如き構造
を有する胆汁酸の一種で、ウルソコール酸
(Ursocholic acid)と呼ばれている。また、ウル
ソデオキシコール酸(Ursodeoxycholic acid)
は、第5図の[]に示す構造式の胆汁酸の一種
であり、日本薬局方に収載され、利胆作用、胃液
分泌促進作用、胆石溶解作用などを有している。
従来、ウルソデオキシコール酸の製造にはコール
酸を出発原料として化学合成法によつてウルソデ
オキシコール酸を合成する方法(例えば、
“APPLIED AND ENVIR ONMENTAL
MICROBIOLOGY”、Vol.44、No.6、1250
[1982];特開昭58−155098号公報)、リトコール
酸から微生物によつて直接ウルソデオキシコール
酸に転換する方法(例えば、特開昭58−155098号
公報、特開昭59−27457号公報)などがあるが、
しかし、いずれもウルソコール酸を出発原料ある
いは中間原料として使用するものではない。ウル
ソコール酸を中間原料としてウルソデオキシコー
ル酸を製造する方法としては、J.デレツク・サザ
ーランド(J.Derek Sutherland)らの方法があ
る。(“Preparative Bioche mistry”Vol.12、No.
4、307−321[1982])。この方法は、コール酸
(cholic acid)を出発原料とし、その7α位の水酸
基を7β位に転換し、次いで、12α位の水酸基を還
元してウルソデオキシコール酸にするものであ
り、その作用機構は、次式に示す通りである。
この反応では、コール酸からウルソコール酸へ
の異性化には2種類の酵素、すなわち7α−ヒド
ロキシステロイドデヒドロゲナーゼと7β−ヒド
ロキシステロイドデヒドロゲナーゼとを使用し、
助酵素としてNADPを使用する。
[発明が解決しようとする問題点]
コール酸からウルソコール酸を経てウルソデオ
キシコール酸を製造することを酵素的に行う方法
においては、天然に大量に存在し水に対する溶解
度が大であるコール酸を原料とし、また有機溶媒
の使用が不要であるので、製造コストが安価とな
り危険性も低減できる。しかしながら、従来方法
においては、コール酸からウルソコール酸への転
換反応において2種類の酵素(7α−ヒドロキシ
ステロイドデヒドロゲナーゼ及び7β−ヒドロキ
システロイドデヒドロゲナーゼ)とNADPとを
必要としており、これが製造コストに大きく影響
を与え、また酵素の安定性に留意する必要があつ
た。すなわち使用酵素が高価であり、また、品質
的安定性を確保することが困難であつた。
[問題を解決するための手段]
本発明者らは、上記従来法における問題点を解
消すべく研究を重ねた結果、ある特定属の微生物
がデオキシコール酸をウルソコール酸に変換する
能力を有するとの知見を得、これにより本発明方
法を完成することによつて、上記問題点を解消す
るに至つたものである。すなわち本発明方法は、
プルロウタス(Pleurotus)属、コリオラス
(Coriolus)属、ダエダレオプシス
(Daedaleopsis)属、パナエオラス(Panaeolus)
属、マラスミウス(Marasmius)属、クリニペ
リス(Crinipellis)属、フオリオタ(Pholiota)
属、フサリウム(Fusarium)属に属する微生物
のうちの1種又はそれ以上をデオキシコール酸と
接触させることにより、該デオキシコール酸をウ
ルソコール酸に変換せしめ、これを採取すること
を特徴とするウルソコール酸の製造法である。
本発明方法において使用するデオキシコール酸
(deoxycholic acid)は、コール酸に次いで動物
の胆汁中に大量に含有されており供給に問題はな
い。
また、本発明方法において使用するウルソコー
ル酸への変換能を有する微生物は、上記の各属か
ら選択され、例えば、プルロウタス・オストレア
タス(Pleurotus ostreatus)、プルロウタス・プ
ルモナリウス(Pleurotus pulmonarius)、プル
ロウタス・セイジヤーカジユ(Pleurotus sajor
−caju)、プルロウタス・サルモネオ−ストラミ
ネウス(Pleurotus salmoneo−stramineus)、コ
リオラス・ベジカラー(Coriolus vesicolor)、
ダエダレオプシス・スチラシナ(Daedaleopsis
styracina)、クリニペリス・スチピタリア
(Crinipellis stipitaria)、パナエオラス・スフイ
ンクトリヌス(Panaeolus sphinctrinus)、フラ
ムリア・ベルテイペス(Flammulia vertipes)、
フオメス・フオメンタリウス(Fomes
fomentarius)、マラスミウス・シツカス
(Marasmius siccus)、フオリタ・ナメコ
(Pholiota nameko)、フサリウム・イクイセチ
(Fusarium equiseti)等を例示することができ
る。これら代表的微生物によつて変換されたウル
ソコール酸の生成量を実施例2の第2表に示す。
第2表に示す各菌株は、いずれも財団法人醗酵研
究所のカタログ(「LIST OF CULTURES」第
7版)に収載された公知寄託菌であり、該研究所
より入手できる。更に、上記の属に属し、常法に
よつて得られた変異株も、ウルソコール酸変換能
を有するものは使用できる。
上記の如き本発明に係る微生物とデオキシコー
ル酸とを接触させる方法としては、使用微生物に
適する栄養培地にデオキシコール酸を添加して培
養を行う方法、使用微生物の培養後の洗浄菌体懸
濁液にデオキシコール酸を溶解させる方法等を適
用できるが、この方法だけに接触方法が限定され
るものはでない。
上記本発明に係る微生物の培養方法は、液体培
養でも固体培養でも適用でき、あるいは培養後に
得られた菌体のみ分離し、これを休止菌体として
使用することもできる。
培地には、炭素源としてキシロース、グルコー
ス、ガラクトース、フラクトース、マンノース、
マルトース、サツカロース、ラフイノース、デン
プン、水アメ、グリセロール、ソルビトールなど
の糖類、酢酸、クエン酸、コハク酸、酪酸、パル
ミチン酸などの有機酸や脂肪酸、エチルアルコー
ル、エタノール、アミルアルコールなどのアルコ
ール類、ヘキサン、オクテンなどの炭化水素類、
または窒素源としてはペプトン、酵母エキス、脱
脂大豆、各種アミノ酸混合物、肉エキス、コーン
スチープリカー、廃糖蜜などの天然窒素源のほか
硫酸アンモニウム、硝酸アンモニウム、塩化アン
モニウム、硝酸ナトリウム、尿素などの無機窒素
を利用できる。この他、必要に応じて、各種ビタ
ミン類、各種無機塩を微量栄養素として添加する
ことができる。これらの配合割合は、利用微生物
の種類に応じて、最も生育しやすいように適宜選
択される。培地のPHも、利用微生物の種類によつ
て異なるが通常PH2〜10程度で、培養温度は約15
〜35℃が好ましい。培養期間は、液体培養の場
合、担止菌で2〜14日、カビで2〜10日、また固
体培養の場合は、担子菌で10〜60日、カビで5〜
30日が適当である。
デオキシコール酸の添加方法は、培地にデオキ
シコール酸を予め添加しておく方法、あるいは培
地で使用微生物が充分に生育したのち、これにデ
オキシコール酸を徐々に添加する方法等を採用で
きるが、デオキシコール酸には微生物の増殖を抑
制する性質があるので、後者方法が好ましい。前
者方法の場合は、デオキシコール酸の添加量は、
約0.5〜20g/とすると好ましい。
また、休止菌体を使用する方法においては、本
発明に係る微生物を予め培養し、次いで菌体を集
め、これを水洗した後、水あるいは緩衝液に懸濁
させる。次いで、この懸濁液にデオキシコール酸
を添加し、通気又は振とうして上記菌体とデオキ
シコール酸とを充分に接触せしめ、もつてデオキ
シコール酸をウルソコール酸に変換させる。この
方法は、前述の如き培地中でデオキシコール酸と
本発明に係る微生物とを接触させる方法とは異な
つて、ウルソコール酸の変換生成する系がほとん
ど水や単純な無機塩溶液であるので、生成物ウル
ソコール酸の精製が容易であり、経済的である。
上述の如き方法によりデオキシコール酸から転換
され生成したウルソコール酸は、通常の方法によ
つて精製する。例えば、培養液あるいは休止菌体
懸濁液を酸性とし、次いでこれに有機溶媒(例え
ば、ジエチルエーテル)を加え、振とうして生成
ウルソコール酸を抽出せしめ、次いで、この有機
溶媒層を濃縮し、シリカゲルカラムでクロマトグ
ラフイを行つてウルソコール酸のフラクシヨンを
分取する。この操作を数回くり返して、結晶化
し、精製ウルソコール酸を得ることができる。
[作 用]
本発明方法は、上述の如く、プルロウタス属、
コリオラス属、ダエダレオプシス属、パナエオラ
ス属、マラスミウス属、クリニペリス属、フオリ
オタ属、フサリウム属に属する微生物のうちの1
種又はそれ以上をデオキシコール酸(第4図中の
[])と接触させることにより、デオキシコール
酸の7β位に水酸基を付加させ、ウルソコール酸
[]に変換せしめるものである。この作用機序
を示すと、第4図に示す式の通りである。
[発明の効果]
上述の発明方法によれば、デオキシコール酸と
上述の如き本発明に係る微生物とを接触させるだ
けで、ウルソコール酸を製造することができ、反
応経路がわずか一段階であるので、極めて処理が
簡単である。しかも、その微生物変換反応に、従
来方法の如き酵素や助酵素[NAD(P)]を別途
供給する必要がないので、より経済的であり、ま
た、それら酵素・助酵素の安定性に留意する必要
も全く解消される。また、原料物質デオキシコー
ル酸は天然に多量に存在するのでその供給に問題
はなく、したがつて、安定的にしかも安価にウル
ソコール酸を製造することができる。
[実施例]
実施例 1
PS培地(バレイシヨ200gの浸出液にシユーク
ロース20gを加え、加水して1とする:「LIST
OF CULTURES、7th ed.」(醗酵研究所発行)
第279頁)にデオキシコール酸500mg添加し溶解さ
せ、これを500ml容坂口フラスコに各100mlづつ10
本に分注、120℃、30分間殺菌後、プルロウタ
ス・オストレアタス(Pleurotus ostreatus)
IFO No.30880を予め斜面培養しておいた培地か
らこのPS培地に接種した。次いで、27℃で8日
間、ロータリーシエイカー(120r.p.m)で振とう
培養した後、この培養液を集合し、これを5規定
HClでPH2〜3とし、次いで2倍容量のジエチル
エーテルを加えて5分間振とう混合して抽出を行
い、次に遠心上澄液を取り、これを濃縮乾固し
た。この乾固物をエチルアルコールに溶解して粗
ウルソコール酸液とし、続いて高速液体クロマト
グラフイーで精製した。高速液体クロマトグラフ
イー装置は、(株)島津製作所製LC−5Aを、カラム
は(株)島津製作所製CLC−ODS(6mmφ×150mm)
を各々使用した。
展開液は10mMリン酸カリウム緩衝液(PH
6.9):アセトニトリル混液(7:3)を用い、流
速0.6ml/分で、1回分の試料チヤージ量は100μ
とした。ウルソコール酸の標準品としては、ア
ラン・F・ホフマン(AlanF.Hofmann:
Division of Gastroenterology、Department of
Medicine、School of Medicine、University of
California;225Dickinson street、San Diego、
California92103、U.S.A.)から入手したウルソ
コール酸を用い、この標準品の高速クロマトグラ
フイーのピークリテンシヨンタイムが
6.9分であることに基づき、本実施例での高速
クロマトグラフイーでは、リテンシヨンタイム
6.2〜8.0分の画分を分取した。このクロマトグラ
フイーを30回行つた。上述の如くして得られた全
フラクシヨンを合わせ、塩酸酸性(PH2〜3)と
した後、2倍量のエーテルを加えて振とう抽出
し、濃縮した。次いで、濃縮液をシリカゲルクロ
マトグラフイー(カラム:10mmφ×300mm、担
体;メルク社製キーゼルゲルArt.7734、70−230
メツシユ、展開液;クロロホルム:メタノール:
水混液[70:25:3])を行い、ウルソコール酸
画分を集め、エタノール水系で結晶化し、ウルソ
コール酸20mgを得た。この生成ウルソコール酸に
ついて、以下の分析を行つた。
(1) 薄層クロマトグラフイー
薄層クロマトグラフイーのプレートはメルク
社製キーゼルゲル60(Art.5721)使用、各種溶
媒で展開した。展開溶媒の組成及び生成ウルソ
コール酸のRf値を第1表に示す。
これらのRf値は、上記ウルソコール酸標準
品のRf値と一致した。(第1表への表示は省略
した。)
(2) ガスクロマトグラフイー
ガスクロマトグラフイー装置は、(株)島津製作
所製GC−9Aを使用、カラム1m、担体として
「ガスクロムQ」、液相にシリコンDC−QF1(2
%)を用いた。カラム温度は220℃、インジエ
クシヨン温度は240℃、キヤリヤーガスに窒素
を使用しFIDで検出した。測定の結果、リテン
シヨンタイム38.8分で、これは、標準品のリテ
ンシヨンタイムと一致した。
(3) 融点測定
生成ウルソコール酸の融点は、134℃、また
標準品の融点は133℃であつた。
(4) 元素分析
生成ウルソコール酸の測定値は、C:67.8、
H:9.72(理論値C:67.0、H:10.0)
(5) 分子量
生成ウルソコール酸の測定値は、409(理論値
408)。
[Industrial Field of Application] The present invention relates to a method for producing ursocholic acid as an intermediate raw material for producing ursodeoxycholic acid. [Prior art] 3α, 7β, 12α-trihydroxy-5β-cholane-
24-acid (3α, 7β, 12α-trihydroxy-5β-
Cholanic acid is a type of bile acid having a structure as shown in [ ] in Figure 4, and is called ursocholic acid. Also, Ursodeoxycholic acid
is a type of bile acid having the structural formula shown in brackets [ ] in Figure 5, is listed in the Japanese Pharmacopoeia, and has choleretic effects, gastric juice secretion promoting effects, and gallstone dissolving effects.
Conventionally, ursodeoxycholic acid has been produced by a chemical synthesis method using cholic acid as a starting material (for example,
“APPLIED AND ENVIR ONMENTAL
MICROBIOLOGY”, Vol.44, No.6, 1250
[1982]; JP-A-58-155098), a method for directly converting lithocholic acid to ursodeoxycholic acid using microorganisms (e.g., JP-A-58-155098, JP-A-59-27457) ), etc.
However, none of these uses ursocholic acid as a starting material or intermediate material. As a method for producing ursodeoxycholic acid using ursocholic acid as an intermediate raw material, there is a method by J. Derek Sutherland et al. (“Preparative Bioche mistry” Vol.12, No.
4, 307-321 [1982]). This method uses cholic acid as a starting material, converts the hydroxyl group at the 7α position to the 7β position, and then reduces the hydroxyl group at the 12α position to produce ursodeoxycholic acid. is as shown in the following equation. In this reaction, two types of enzymes are used to isomerize cholic acid to ursocholic acid, namely 7α-hydroxysteroid dehydrogenase and 7β-hydroxysteroid dehydrogenase.
Use NADP as a coenzyme. [Problems to be solved by the invention] In the enzymatic method of producing ursodeoxycholic acid from cholic acid via ursocholic acid, cholic acid, which naturally exists in large quantities and has high solubility in water, is used. Since it is not necessary to use organic solvents as raw materials, manufacturing costs are low and risks can be reduced. However, in the conventional method, two types of enzymes (7α-hydroxysteroid dehydrogenase and 7β-hydroxysteroid dehydrogenase) and NADP are required for the conversion reaction from cholic acid to ursocholic acid, which greatly affects the production cost. In addition, it was necessary to pay attention to the stability of the enzyme. That is, the enzymes used were expensive and it was difficult to ensure quality stability. [Means for Solving the Problems] As a result of repeated research to solve the problems with the above-mentioned conventional methods, the present inventors have discovered that a certain genus of microorganisms has the ability to convert deoxycholic acid into ursocholic acid. By obtaining this knowledge and completing the method of the present invention based on this knowledge, the above-mentioned problems have been solved. That is, the method of the present invention
Pleurotus, Coriolus, Daedaleopsis, Panaeolus
Genus, Marasmius, Crinipellis, Pholiota
Ursocholic acid, characterized in that the deoxycholic acid is converted into ursocholic acid by contacting one or more types of microorganisms belonging to the genus Fusarium with deoxycholic acid, and the ursocholic acid is collected. This is the manufacturing method. Deoxycholic acid used in the method of the present invention is contained in large quantities in animal bile, second only to cholic acid, and there is no problem in supplying it. Furthermore, the microorganisms having the ability to convert ursocholic acid used in the method of the present invention are selected from the above-mentioned genera, and include, for example, Pleurotus ostreatus, Pleurotus pulmonarius, Pleurotus sagejakajiyu, and Pleurotus pulmonarius. (Pleurotus sajor
-caju), Pleurotus salmoneo-stramineus, Coriolus vesicolor,
Daedaleopsis styracina (Daedaleopsis)
styracina), Crinipellis stipitaria, Panaeolus sphinctrinus, Flammulia vertipes,
Fomes fuomentarius
fomentarius), Marasmius siccus, Pholiota nameko, Fusarium equiseti, and the like. Table 2 of Example 2 shows the amount of ursocholic acid produced by these representative microorganisms.
The strains shown in Table 2 are all publicly known deposited bacteria listed in the Fermentation Research Institute's catalog ("LIST OF CULTURES" 7th edition), and can be obtained from the Institute. Furthermore, mutant strains belonging to the above-mentioned genera and obtained by conventional methods can also be used as long as they have the ability to convert ursocholic acid. Methods for bringing the microorganism according to the present invention into contact with deoxycholic acid as described above include a method of culturing by adding deoxycholic acid to a nutrient medium suitable for the microorganism used, and a method of culturing by adding deoxycholic acid to a nutrient medium suitable for the microorganism used, and washing and suspending bacterial cells after culturing the microorganism used. A method such as dissolving deoxycholic acid in a liquid can be applied, but the contact method is not limited to this method. The method for culturing microorganisms according to the present invention can be applied to either liquid culture or solid culture, or it is also possible to isolate only the microbial cells obtained after culturing and use them as resting microbial cells. The medium contains xylose, glucose, galactose, fructose, mannose, and
Saccharides such as maltose, sutucarose, raffinose, starch, starch syrup, glycerol, sorbitol, organic acids and fatty acids such as acetic acid, citric acid, succinic acid, butyric acid, palmitic acid, alcohols such as ethyl alcohol, ethanol, amyl alcohol, hexane , hydrocarbons such as octene,
Alternatively, use natural nitrogen sources such as peptone, yeast extract, defatted soybeans, various amino acid mixtures, meat extract, corn steep liquor, and blackstrap molasses, as well as inorganic nitrogen sources such as ammonium sulfate, ammonium nitrate, ammonium chloride, sodium nitrate, and urea. can. In addition, various vitamins and various inorganic salts can be added as micronutrients, if necessary. These blending ratios are appropriately selected depending on the type of microorganism to be used so that it can grow most easily. The pH of the culture medium also varies depending on the type of microorganism used, but it is usually around PH2 to 10, and the culture temperature is around 15.
~35°C is preferred. In the case of liquid culture, the culture period is 2 to 14 days for basidiomycetes and 2 to 10 days for molds, and in the case of solid culture, it is 10 to 60 days for basidiomycetes and 5 to 5 days for molds.
30 days is appropriate. Deoxycholic acid can be added by adding deoxycholic acid to the medium in advance, or gradually adding deoxycholic acid to the microorganisms used after they have grown sufficiently in the medium. The latter method is preferred since deoxycholic acid has the property of inhibiting the growth of microorganisms. In the case of the former method, the amount of deoxycholic acid added is
The amount is preferably about 0.5 to 20 g/. In addition, in a method using dormant bacterial cells, the microorganism according to the present invention is cultured in advance, the bacterial cells are collected, washed with water, and then suspended in water or a buffer solution. Next, deoxycholic acid is added to this suspension, and the bacterial cells are brought into sufficient contact with the deoxycholic acid by aeration or shaking, thereby converting the deoxycholic acid into ursocholic acid. This method differs from the method described above in which deoxycholic acid is brought into contact with the microorganism according to the present invention in a medium, since the system in which ursocholic acid is converted and produced is mostly water or a simple inorganic salt solution. Purification of ursocholic acid is easy and economical.
Ursocholic acid produced by conversion from deoxycholic acid by the method described above is purified by a conventional method. For example, a culture solution or a suspension of resting bacterial cells is made acidic, an organic solvent (for example, diethyl ether) is added thereto, the ursocholic acid produced is extracted by shaking, and the organic solvent layer is then concentrated. Perform chromatography on a silica gel column to separate a fraction of ursocholic acid. This operation can be repeated several times to crystallize and obtain purified ursocholic acid. [Function] As mentioned above, the method of the present invention is applicable to the genus Pleurotus,
One of the microorganisms belonging to the genera Coriolus, Daedaleopsis, Panaeolus, Marasmius, Cliniperis, Fuoriota, and Fusarium
By bringing one or more species into contact with deoxycholic acid ([] in Figure 4), a hydroxyl group is added to the 7β position of deoxycholic acid, converting it to ursocholic acid []. The mechanism of action is shown in the equation shown in FIG. [Effects of the Invention] According to the method of the invention described above, ursocholic acid can be produced simply by bringing deoxycholic acid into contact with the microorganism according to the present invention as described above, and the reaction path is only one step. , extremely easy to process. Moreover, the microbial conversion reaction does not require the separate supply of enzymes and coenzymes [NAD(P)] as in conventional methods, making it more economical and requiring consideration of the stability of the enzymes and coenzymes. The need is completely eliminated. Further, since the raw material deoxycholic acid exists in large amounts naturally, there is no problem in its supply, and therefore ursocholic acid can be produced stably and at low cost. [Example] Example 1 PS medium (add 20 g of sucrose to the exudate of 200 g of potato, add water to make 1: "LIST
OF CULTURES, 7th ed.” (Published by Fermentation Research Institute)
Add 500 mg of deoxycholic acid to (p.
Dispense into books, sterilize at 120℃ for 30 minutes, and then add Pleurotus ostreatus.
This PS medium was inoculated from a medium in which IFO No. 30880 had been cultured on a slope in advance. Next, after shaking culture in a rotary shaker (120 rpm) at 27°C for 8 days, the culture solution was collected and diluted with 5N
The pH was adjusted to 2 to 3 with HCl, then twice the volume of diethyl ether was added, and the mixture was shaken and mixed for 5 minutes for extraction.Then, the centrifuged supernatant was collected and concentrated to dryness. This dried product was dissolved in ethyl alcohol to obtain a crude ursocholic acid solution, which was then purified by high performance liquid chromatography. The high-performance liquid chromatography device was LC-5A manufactured by Shimadzu Corporation, and the column was CLC-ODS (6 mmφ x 150 mm) manufactured by Shimadzu Corporation.
were used respectively. The developing solution is 10mM potassium phosphate buffer (PH
6.9): Using an acetonitrile mixture (7:3) at a flow rate of 0.6 ml/min, the sample charge amount for one time is 100 μ
And so. As a standard product of ursocholic acid, Alan F. Hofmann (Alan F. Hofmann:
Division of Gastroenterology, Department of
Medicine, School of Medicine, University of
California; 225 Dickinson street, San Diego;
Based on the fact that the peak retention time of this standard product in high-speed chromatography is 6.9 minutes, the retention time was
A fraction of 6.2 to 8.0 minutes was collected. This chromatography was performed 30 times. All the fractions obtained as described above were combined, acidified with hydrochloric acid (PH 2-3), extracted with shaking by adding twice the amount of ether, and concentrated. Next, the concentrated solution was subjected to silica gel chromatography (column: 10 mmφ x 300 mm, carrier: Merck Kieselgel Art.7734, 70-230).
mesh, developing solution; chloroform: methanol:
The ursocholic acid fraction was collected and crystallized from an aqueous ethanol system to obtain 20 mg of ursocholic acid. The following analysis was performed on the produced ursocholic acid. (1) Thin layer chromatography The thin layer chromatography plate used was Merck Kieselgel 60 (Art. 5721) and was developed with various solvents. Table 1 shows the composition of the developing solvent and the Rf value of the produced ursocholic acid. These Rf values matched those of the ursocholic acid standard product. (Display in Table 1 has been omitted.) (2) Gas chromatography The gas chromatography equipment used was GC-9A manufactured by Shimadzu Corporation, column 1m, "Gaschrome Q" as a carrier, and silicon in the liquid phase. DC−QF1(2
%) was used. The column temperature was 220°C, the injection temperature was 240°C, nitrogen was used as the carrier gas, and detection was performed using FID. As a result of the measurement, the retention time was 38.8 minutes, which matched the retention time of the standard product. (3) Melting point measurement The melting point of the produced ursocholic acid was 134°C, and that of the standard product was 133°C. (4) Elemental analysis The measured value of produced ursocholic acid is C: 67.8,
H: 9.72 (theoretical value C: 67.0, H: 10.0) (5) Molecular weight The measured value of the produced ursocholic acid is 409 (theoretical value
408).
【表】
(6) 赤外吸収
本発明方法による生成ウルソコール酸のスペ
クトル[A]、及び標準品のスペクトル[B]
を第1図に示す。
(7) NMR
本発明方法による生成ウルソコール酸のスペ
クトルを第2図に、標準品のスペクトルを第3
図に示す。
実施例 2
実施例1と同組成のPS培地1を調製し、こ
れにデオキシコール酸500mg添加し溶解させたも
のを本培養培地とした。この培地を500ml容坂口
フラスコ10本に各100ml分注し、120℃、30分間殺
菌後、第2表に示す微生物を予め斜面培養してお
いた培地から、この本培養培地に接種した。次い
で、実施例1と同様の培養条件で培養し、以下、
実施例1と同様方法でウルソコール酸の変換生成
反応及び精製処理を行つた。第2表に示す各微生
物について、各々上述の如き処理を実施し、その
結果得られたウルソコール酸の生成量を各々第2
表に示す。
実施例 3
大豆粉−デンプン培地(全大豆粉20g、可溶性
デンプン30g、KH2PO4・2H2O1g、MgSO4・
7H2O0.5g、CaCl2・2H2O0.5gを水1に溶解)
100mlを500ml容坂口フラスコに分注し、120℃20
分間殺菌した。この培地にプルロウタス・セイジ
ヤーカジユ(Pleurotus sajor−caju)IFO No.
30167を接種し、27℃で4日間ロータリーシエー
カー(120r.p.m)で振とう培養し、種菌とした。
次いで文本培養培地(脱脂コーン粕10g、デキス
トリン20g、K2HPO417.4g、MgSO4・7H2O0.5
g、CaCl2・2H2O0.5gおよびデオキシコール酸
0.5gを水1に溶解)100mlを500ml容坂口フラ
スコに分注し、前記種菌培養と同条件下で8日間
培養した。この培養液を5規定塩酸でPH2〜3と
した後、2倍量のジエチルエーテルを加えて、5
分間振とう抽出し、その遠心上澄を取り濃縮乾固
した。得られた乾固物をエタノール20mlに溶解
し、[Table] (6) Infrared absorption Spectrum of ursocholic acid produced by the method of the present invention [A] and spectrum of standard product [B]
is shown in Figure 1. (7) NMR The spectrum of ursocholic acid produced by the method of the present invention is shown in Figure 2, and the spectrum of the standard product is shown in Figure 3.
As shown in the figure. Example 2 PS medium 1 having the same composition as in Example 1 was prepared, and 500 mg of deoxycholic acid was added and dissolved therein to form the main culture medium. 100 ml of this medium was dispensed into ten 500 ml Sakaguchi flasks each, and after sterilization at 120°C for 30 minutes, the microorganisms shown in Table 2 were inoculated into this main culture medium from the medium previously cultured on a slant. Next, culturing was carried out under the same culture conditions as in Example 1, and the following
The conversion production reaction and purification treatment of ursocholic acid were carried out in the same manner as in Example 1. Each of the microorganisms shown in Table 2 was treated as described above, and the resulting amount of ursocholic acid produced was
Shown in the table. Example 3 Soybean flour-starch medium (20 g of whole soybean flour, 30 g of soluble starch, 1 g of KH 2 PO 4 , 2H 2 O, MgSO 4
7H 2 O 0.5g, CaCl 2・2H 2 O 0.5g dissolved in 1 part water)
Dispense 100ml into a 500ml Sakaguchi flask and heat at 120℃20.
Sterilized for minutes. In this medium, Pleurotus sajor-caju IFO No.
30167 was inoculated and cultured at 27° C. for 4 days with shaking in a rotary shaker (120 rpm) to use as an inoculum.
Next, we added text culture medium (10 g of defatted corn meal, 20 g of dextrin, 17.4 g of K 2 HPO 4 , MgSO 4.7H 2 O0.5
g, CaCl2・2H2O0.5g and deoxycholic acid
(0.5 g dissolved in 1 part water) 100 ml was dispensed into a 500 ml Sakaguchi flask and cultured for 8 days under the same conditions as the seed culture described above. After adjusting the pH of this culture solution to 2 to 3 with 5N hydrochloric acid, 2 times the amount of diethyl ether was added.
Extraction was carried out by shaking for a minute, and the centrifuged supernatant was collected and concentrated to dryness. Dissolve the obtained dry matter in 20 ml of ethanol,
【表】【table】
【表】
再結晶させて粗ウルソコール酸6.1mgを得た。
実施例 4
上記実施例2と同様の各培地で、フサリウム・
イクイセチ(Fusarium equiseti)IFO No.31095
の種菌培養および本培養を行つた。ただし、本実
施例においては、本培養培地へのデオキシコール
酸の添加量は1.0g/とした。実施例2と同様
にして培養し、得られた培養液を、実施例2と同
様に処理して粗ウルソコール酸460mgを得た。こ
の粗ウルソコール酸を実施例1と同条件で高速液
体クロマトグラフイーおよびシリカゲルカラムク
ロマトグラフイーを行い、薄層クロマトグラフイ
ー的にほぼ単一のウルソコール酸約230mgを得た。
実施例 5
実施例1と同じ組成のPS培地を500ml容坂口フ
ラスコ3本に各100mlずつ分注し、高圧殺菌した。
次いで予め斜面培養しておいたフサリウム・イク
イセチ(Fusarium equiseti)IFO No.31095を接
種し、28℃で4日間ロータリーシエイカー
(120r.p.m.)で振とう培養を行い、これを種菌と
し、その200mlを下記組成の培地2.5を入れた培
養器(5容)で通気撹はん培養を行つた。培養
条件は28℃、通気量1/min.で撹はん数120r.
p.m.とした。
培地組成 シユクロース 40g/
ペプトン 10 〃
酵母エキス 1 〃
K2HPO4 17.4 〃
MgSO4・7H2O 0.5 〃
CaCl2・2H2O 0.5 〃
デオキシコール酸 0.5 〃
ミネラル(注) 1ml/
(注)ミネラル FeSO4・7H2O 1g/
MnSO4・6H2O 1 〃
ZnSO4・4H2O 1 〃
CuSO4・5H2O 1 〃
NaMO6・2H2O 1 〃
培養終了後、培養液をさらしでろ過し、培養中
に生じた菌糸体を胞子とろ別し、さらに遠心分離
(10000r.p.m.、15min.)し、胞子を集めた。得ら
れた胞子を無菌水で胞子数2×1010/mlの懸濁液
とし、その10mlにデオキシコール酸、リン酸緩衝
液(PH7.5)をそれぞれ0.5g/、0.1Mとなるよ
うに添加して100mlとした。次いで、その100mlを
500ml容坂口フラスコに分注し、28℃で3日間ロ
ータリーシエイカー(120r.p.m.)で振とう培養
し、接種後64時間目に実施例1と同じ方法で抽出
精製し、0.25g/のウルソコール酸を得た。[Table] 6.1 mg of crude ursocholic acid was obtained by recrystallization. Example 4 Using the same culture medium as in Example 2 above, Fusarium
Fusarium equiseti IFO No.31095
Inoculum culture and main culture were performed. However, in this example, the amount of deoxycholic acid added to the main culture medium was 1.0 g/. Culture was carried out in the same manner as in Example 2, and the resulting culture solution was treated in the same manner as in Example 2 to obtain 460 mg of crude ursocholic acid. This crude ursocholic acid was subjected to high performance liquid chromatography and silica gel column chromatography under the same conditions as in Example 1, to obtain approximately 230 mg of substantially single ursocholic acid as determined by thin layer chromatography. Example 5 A PS medium having the same composition as in Example 1 was dispensed into three 500 ml Sakaguchi flasks at 100 ml each and sterilized under high pressure.
Next, Fusarium equiseti IFO No. 31095, which had been cultured on a slope in advance, was inoculated and cultured with shaking in a rotary shaker (120 rpm) at 28°C for 4 days. was cultured with aeration in an incubator (5 volumes) containing 2.5 volumes of a medium with the following composition. The culture conditions were 28℃, aeration rate of 1/min, and stirring rate of 120r.
It was set as pm. Medium composition Sucrose 40g / Peptone 10 〃 Yeast extract 1 〃 K 2 HPO 4 17.4 〃 MgSO 4・7H 2 O 0.5 〃 CaCl 2・2H 2 O 0.5 〃 Deoxycholic acid 0.5 〃 Mineral (Note) 1 ml / (Note) Mineral FeSO 4・7H 2 O 1g/ MnSO 4・6H 2 O 1 〃 ZnSO 4・4H 2 O 1 〃 CuSO 4・5H 2 O 1 〃 NaMO 6・2H 2 O 1 〃 After the cultivation, filter the culture solution The mycelium produced during the culture was filtered from the spores, and further centrifuged (10,000 rpm, 15 min.) to collect the spores. The obtained spores were made into a suspension with sterile water at a spore count of 2 x 10 10 /ml, and to 10ml of this suspension was added deoxycholic acid and phosphate buffer (PH7.5) at a concentration of 0.5g/0.1M, respectively. was added to make 100 ml. Then, add that 100ml to
It was dispensed into a 500 ml Sakaguchi flask, cultured at 28°C for 3 days with shaking in a rotary shaker (120 rpm), and 64 hours after inoculation, it was extracted and purified using the same method as in Example 1, and 0.25 g/Ursocol was extracted and purified using the same method as in Example 1. Obtained acid.
第1図は、本発明方法による生成ウルソコール
酸[A]およびウルソコール酸標準品[B]の赤
外線吸収スペクトルである。比較を容易にするた
め、両者上下に若干ずらして図示した。第2図
は、本発明方法による生成ウルソコール酸の
NMRスペクトルを示し、また、第3図は、ウル
ソコール酸標準品のNMRスペクトルを示す。第
4図は、本発明方法における作用機序を示す式で
あり、[]はデオキシコール酸であり、[]は
ウルソコール酸である。第5図は、ウルソコール
酸[]からウルソデオキシコール酸[]を生
成する反応式を示す。
FIG. 1 shows infrared absorption spectra of ursocholic acid [A] produced by the method of the present invention and standard ursocholic acid [B]. For ease of comparison, both are shown slightly shifted vertically. Figure 2 shows the ursocholic acid produced by the method of the present invention.
Figure 3 shows the NMR spectrum of a standard ursocholic acid. FIG. 4 is a formula showing the mechanism of action in the method of the present invention, where [ ] is deoxycholic acid and [ ] is ursocholic acid. FIG. 5 shows a reaction formula for producing ursodeoxycholic acid [] from ursocholic acid [].
Claims (1)
(Coriolus)属、ダエダレオプシス
(Daedaleopsis)属、パナエオラス(Panaeolus)
属、マラスミウス(Marasmius)属、クリニペ
リス(Crinipellis)属、フオリオタ(Pholiota)
属、フサリウム(Fusarium)属に属する微生物
のうちの1種又はそれ以上をデオキシコール酸と
接触させることによりデオキシコール酸をウルソ
コール酸に変換せしめ、これを採取することを特
徴とするウルソコール酸の製造法。1. Pleurotus, Coriolus, Daedaleopsis, Panaeolus
Genus, Marasmius, Crinipellis, Pholiota
Production of ursocholic acid, which comprises converting deoxycholic acid into ursocholic acid by contacting one or more microorganisms belonging to the genus Fusarium with deoxycholic acid, and collecting the same. Law.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11155385A JPS61268196A (en) | 1985-05-23 | 1985-05-23 | Production of ursocholic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11155385A JPS61268196A (en) | 1985-05-23 | 1985-05-23 | Production of ursocholic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61268196A JPS61268196A (en) | 1986-11-27 |
| JPH0134038B2 true JPH0134038B2 (en) | 1989-07-17 |
Family
ID=14564303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11155385A Granted JPS61268196A (en) | 1985-05-23 | 1985-05-23 | Production of ursocholic acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61268196A (en) |
-
1985
- 1985-05-23 JP JP11155385A patent/JPS61268196A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61268196A (en) | 1986-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101760494A (en) | Biofermentation method for androstendione by using resting cell | |
| JPH0775589A (en) | Method for producing protocatechuic acid | |
| JPS6130552B2 (en) | ||
| JPS6314950B2 (en) | ||
| JPH0529438B2 (en) | ||
| JPH0134038B2 (en) | ||
| JP3589685B2 (en) | Biological production of 25-position hydroxide of steroids | |
| US3801460A (en) | Simultaneous steroid oxygenation and 1-dehydrogenation with bacillus cereus | |
| JP3030916B2 (en) | Method for producing β-glucooligosaccharide | |
| JPH07242636A (en) | FO-3216 substance and its manufacturing method | |
| JPH0352884A (en) | Fo-608a substance and production thereof | |
| US2872380A (en) | Process for the production of 17-beta hydroxysteroids by neocosmospora | |
| FR2510138A1 (en) | PROCESS FOR THE PRODUCTION OF 9-HYDROXY-3-OXO-4,17 (20) -REGNADIENE-20-CARBOXALDEHYDE BY FERMENTATION AND PRODUCT OBTAINED | |
| JP2676248B2 (en) | L-carnitine production method | |
| JPH0665319B2 (en) | Process for producing 1-methyl-1,4-androstagen-3,17-dione | |
| JP3030896B2 (en) | WB968 substance group and production method thereof | |
| JP3434860B2 (en) | FO-2546 substance and method for producing the same | |
| JPH0662576B2 (en) | Mycotrienin compounds | |
| JP3862277B2 (en) | Novel bile acid converting microorganism | |
| JPH06225793A (en) | New production of 6beta,14alpha-dihydroxy-4-androstene3,17-dione | |
| JPH0823989A (en) | Method for producing oligosaccharide having high panose content | |
| JPH05268944A (en) | Novel bile acid-converting microorganism and method for producing bile acid | |
| JPH07213295A (en) | Method for producing 4-hydroxy-2-methylbenzoic acid using microorganism | |
| JPH06153987A (en) | New production of 14alpha-hydroxy-4-androstene-3,17-dione | |
| JPS61280293A (en) | Production of phosphoric acid ester of steroid compound |